GTEx Heart 20-29 vs 30-39 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Heart 20-29 vs 30-39 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Heart 20-29 vs 30-39 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Heart 20-29 vs 30-39 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Heart 20-29 vs 30-39 Up.

Results found

Linked to

 

Label

Description

 

Gene

p53 upregulated regulator of p53 levels

Gene

long non coding transcriptional activator of miR34a

Gene

TSPEAR antisense RNA 1

Gene

cytochrome P450 family 4 subfamily F member 29, pseudogene

Gene

uncharacterized LOC157273

Gene

GATA3 antisense RNA 1

Gene

long intergenic non-protein coding RNA 648

Gene

H4 clustered histone 2

Gene

long intergenic non-protein coding RNA 298

Gene

keratoconus gene 6

  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    long non coding transcriptional activator of miR34a


  • Gene

    TSPEAR antisense RNA 1


  • Gene

    cytochrome P450 family 4 subfamily F member 29, pseudogene


  • Gene

    uncharacterized LOC157273


  • Gene

    GATA3 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 648


  • Gene

    H4 clustered histone 2


  • Gene

    long intergenic non-protein coding RNA 298


  • Gene

    keratoconus gene 6

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.